Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Outsourcing

Hanko to step down at Siegfried

by Rick Mullin
June 10, 2018 | A version of this story appeared in Volume 96, Issue 24

A photo of Rudolf Hanko
Credit: Rick Mullin/C&EN
Rudolf Hanko

Siegfried, the Swiss pharmaceutical contract development and manufacturing firm, says Rudolf Hanko, CEO since 2009, will step down at the end of the year. Wolfgang Wienand, currently chief scientific and strategy officer for the firm, will succeed Hanko. Before Siegfried, Hanko headed Bayer’s pharmaceutical division. During his tenure, Siegfried’s annual sales tripled to nearly $710 million, partly through the acquisition of BASF’s custom pharmaceutical chemical business. He also oversaw the construction and launch in 2016 of a major manufacturing facility in China. Hanko is up for election to the company’s board of directors.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.